Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tolerability”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03038113
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Hoffmann-La Roche 119
Early research (Phase 1)Study completedNCT02974374
What this trial is testing

Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects

Who this might be right for
Non-alcoholic Fatty Liver Disease
Pfizer 16
Early research (Phase 1)Ended earlyNCT05039710
What this trial is testing

JNJ-75220795 in Japanese Participants

Who this might be right for
Fatty Liver
Janssen Pharmaceutical K.K. 9
Early research (Phase 1)Looking for participantsNCT06270706
What this trial is testing

PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumor
Pliant Therapeutics, Inc. 124
Testing effectiveness (Phase 2)Ended earlyNCT05099549
What this trial is testing

Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers

Who this might be right for
Squamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell LungColorectal Neoplasms+3 more
NKGen Biotech, Inc. 11
Early research (Phase 1)Study completedNCT00982826
What this trial is testing

Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Food on the Pharmacokinetics of ABT-072

Who this might be right for
Hepatitis C
Abbott 52
Testing effectiveness (Phase 2)UnknownNCT03946917
What this trial is testing

JS001 Combined With Regorafenib in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 44
Early research (Phase 1)Looking for participantsNCT07416552
What this trial is testing

Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
Hoffmann-La Roche 180
Testing effectiveness (Phase 2)Looking for participantsNCT07563738
What this trial is testing

A 2-part Phase 1/2 Open-label Trial on ODM-212

Who this might be right for
MesotheliomaPancreatic CancerNSCLC (Advanced Non-small Cell Lung Cancer)
Orion Corporation, Orion Pharma 229
Testing effectiveness (Phase 2)Looking for participantsNCT06747858
What this trial is testing

Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis

Who this might be right for
Cystic FibrosisCFTR Gene Mutation
Arcturus Therapeutics, Inc. 33
Early research (Phase 1)Study completedNCT03515980
What this trial is testing

An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function

Who this might be right for
Liver DysfunctionLiver InsufficiencyHepatic Failure+4 more
Bristol-Myers Squibb 76
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Early research (Phase 1)Ended earlyNCT05757492
What this trial is testing

Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorNon-Small Cell Lung CancerHepatocellular Carcinoma
Coherus Oncology, Inc. 22
Testing effectiveness (Phase 2)WithdrawnNCT02321306
What this trial is testing

An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis

Who this might be right for
Primary Biliary Cirrhosis
Mirum Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT04168333
What this trial is testing

Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B Virus (HBV)
Tasly Tianjin Biopharmaceutical Co., Ltd. 36
Early research (Phase 1)Study completedNCT06340347
What this trial is testing

Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function

Who this might be right for
Liver Diseases
Pfizer 8
Large-scale testing (Phase 3)Ended earlyNCT02058108
What this trial is testing

Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B
Novartis Pharmaceuticals 53
Not applicableStudy completedNCT02598817
What this trial is testing

Acceptability and Gastrointestinal Tolerance of a High-Sn-2 Infant Formula

Who this might be right for
Infant Term Birth
Société des Produits Nestlé (SPN) 276
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT02550418
What this trial is testing

Budesonide 9 mg Capsules in Active UC

Who this might be right for
Colitis, Ulcerative
Dr. Falk Pharma GmbH 60
Next Page